| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.43B | +0.8% |
| Gross profit | ¥0.61B | — |
| Operating income | ¥0.39B | — |
| Net income | ¥0.33B | +13.1% |
| Gross margin | 42.8% | Net margin 22.8% |
| Revenue Q/Q | -8.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.82B | 57.2% |
| R&D | ¥0.01B | 0.7% |
| SG&A | ¥0.11B | 7.7% |
| Tax & other | ¥0.07B | 4.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
和顺电气 ・ 沃森生物 ・ 盈康生命 ・ 宋城演艺 ・ 南方泵业 ・ 汤臣倍健 ・ *ST香雪 ・ 天舟文化 ・ 睿智医药 ・ 世纪瑞尔 ・ 昌红科技 ・ *ST动力
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies